Clinical utility of serum Interleukin-1 receptor antagonist levels as a diagnostic and prognostic assay in surgical patients

被引：0
|
作者：
Shailendra Kapoor
机构：
来源：
Langenbeck's Archives of Surgery | 2009年 / 394卷
关键词：
Thyroid Cancer; Follicular Carcinoma; Hairy Cell Leukemia; Hairy Cell; Anaplastic Carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：401 / 402
页数：1
相关论文
共 50 条
  • [31] Clinical relevance of interleukin-1 receptor antagonist plasma levels in renal transplant recipients
    Daniel, V
    Pasker, S
    Weimer, R
    Melk, A
    Zipperle, S
    Schnobel, R
    Carl, S
    Wiesel, M
    Staehler, G
    Opelz, G
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1998, 25 (01): : 35 - 38
  • [32] Interleukin-1 receptor antagonist and interleukin-1 beta polymorphisms in patients with asthma in Venezuela
    Larocca, N. E.
    Moreno, D.
    Garmendia, J.
    Toro, F.
    De Sanctis, J. B.
    ALLERGY, 2013, 68 : 531 - 531
  • [33] Interleukin-1 receptor antagonist and interleukin-6 as markers of surgical trauma
    Slotwinski, R
    Lech, G
    Gomula, J
    Zaleska, M
    Malyszka, K
    Szczygiel, B
    5TH WORLD CONGRESS ON TRAUMA, SHOCK, INFLAMMATION AND SEPSIS: PATHOPHYSIOLOGY, IMMUNE CONSEQUENCES AND THERAPY, 2000, : 425 - 430
  • [34] Increased serum levels of interleukin-1 receptor antagonist in human obesity: A link to the resistance to leptin?
    Meier, CA
    Bobbioni, E
    Gabay, C
    Assimacoloulos-Jeannet, F
    Golay, A
    Dayer, JM
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, : 94 - 94
  • [35] Increased level of serum interleukin-1 receptor antagonist subsequent to resolution of clinical symptoms in patients with West syndrome
    Yamanaka, Gaku
    Kawashima, Hisashi
    Oana, Shingo
    Ishida, Yu
    Miyajima, Tasuku
    Kashiwagi, Yasuyo
    Hoshika, Akinori
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 298 (1-2) : 106 - 109
  • [36] A Functional Interleukin-1 Receptor Antagonist Polymorphism Influences Atherosclerosis Development - The Interleukin-1β:Interleukin-1 Receptor Antagonist Balance in Atherosclerosis -
    Olofsson, Peder S.
    Sheikine, Yuri
    Jatta, Ken
    Ghaderi, Mehran
    Samnegard, Ann
    Eriksson, Per
    Sirsjoe, Allan
    CIRCULATION JOURNAL, 2009, 73 (08) : 1531 - 1536
  • [37] Reduced levels of interleukin-1 receptor antagonist in the cerebrospinal fluid in patients with West syndrome
    Haginoya, Kazuhiro
    Noguchi, Rie
    Zhao, Yajuan
    Munakata, Mitsutoshi
    Yokoyama, Hiroyuki
    Tanaka, Soichiro
    Hino-Fukuyo, Naomi
    Uematsu, Mitsugu
    Yamamoto, Katsuya
    Takayanagi, Masaru
    Iinuma, Kazuie
    Tsuchiya, Shigeru
    EPILEPSY RESEARCH, 2009, 85 (2-3) : 314 - 317
  • [38] Effects of treatment with interleukin-1 receptor antagonist on endogenous interleukin-1 levels in normal and irradiated mice
    Bugarski, D
    Jovcic, G
    Kataranovski, M
    Ivanovic, Z
    Petakov, M
    Stojanovic, N
    Milenkovic, P
    PHYSIOLOGICAL RESEARCH, 2000, 49 (03) : 355 - 362
  • [39] Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites
    Ishihara, Y
    Nishihara, T
    Kuroyanagi, T
    Shirozu, N
    Yamagishi, E
    Ohguchi, M
    Koide, M
    Ueda, N
    Amano, K
    Noguchi, T
    JOURNAL OF PERIODONTAL RESEARCH, 1997, 32 (06) : 524 - 529
  • [40] Circulating interleukin-1 receptor antagonist (IL-1RA) serum levels in patients undergoing orthotopic heart transplantation
    Thiele, RI
    Daniel, V
    Opelz, G
    Lange, R
    Sack, FU
    Jakob, H
    Hagl, S
    TRANSPLANT INTERNATIONAL, 1998, 11 (06) : 443 - 448
12345